Comparison

EP300/CBP-IN-1 European Partner

Item no. HY-160260
Manufacturer MedChem Express
CASRN 2638507-71-6
Amount 1 ea
Specific against other
Citations [1]Lei Fan, et al. An EP300/CBP inhibitor. CN112574189A.
Smiles O=C1N(C2=CC(F)=C(C=C2)Cl)[C@@H](CCO1)C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@H]6CC[C@@H](CC6)OCC
Available
Product Description
EP300/CBP-IN-1 (compound 172) is a potent EP300/CBP inhibitor with IC50s of 2.3 nM and 2.1 nM for CBP BRD and EP300 BRD, respectively. EP300/CBP-IN-1 has the inhibitory effect on the proliferation of prostate cancer CWR22RV1 cells[1].
Shipping
Room temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
567.05
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
10 mM in DMSO
Target
Epigenetic Reader Domain; Histone Acetyltransferase
Manufacturers Target
Epigenetic Reader Domain; Histone Acetyltransferase
Manufacturers Pathway
Epigenetics
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close